BrP-LPA
BrP-LPA is a LPA antagonist/ATX inhibitor. BrP-LPA shows pan-antagonist activity towards LPA1-4 GPCRs. BrP-LPA decreases blood vessel density. BrP-LPA dose-dependently inhibits Lysophosphatidic acid-induced head-dip counts. BrP-LPA exhibits anticancer activity against breast cancer, colon cancer, and lung cancer. BrP-LPA inhibits anxiety-like behavior.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 944313-05-7
- Formule: C20H40BrO6P
- Masse moléculaire:487.41
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
LPA1 Receptor |
LPA2 Receptor |
LPA3 Receptor |
LPA4 Receptor |
Chemical Information
-
CAS No. 944313-05-7
-
Masse moléculaire 487.41
-
Formule C20H40BrO6P
-
SMILES
OP(O)(C(Br)C[C@H](O)COC(CCCCCCCCCCCCCCC)=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Xu X, et al. Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors. Prostaglandins Other Lipid Mediat. 2009 Sep;89(3-4):140-6. [Content Brief]
[2]. Yamada M, et al. Lysophosphatidic acid induces anxiety-like behavior via its receptors in mice. J Neural Transm (Vienna). 2015 Mar;122(3):487-94. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
BrP-LPA Related Classifications
HY-W725737 Related Classifications
Powered by Bioz